Lymph nodes in the irradiated field influence the yield of radiation-induced chromosomal aberrations in lymphocytes from breast cancer patients

International Journal of Radiation Oncology Biology Physics

Volumn 57, Issue 3, 2003, Pages 732-738

  D'Alesio, Valentina ^a,b   Pacelli, Roberto ^c   Durante, Marco ^a,b   Cama, Gustavo Canale ^a   Cella, Laura ^c   Gialanella, Giancarlo ^a,b   Grossi, Gianfranco ^a,b   Pugliese, Mariagabriella ^a,b   Punzo, Giorgio ^c   Sardi, Ilaria ^a   Scampoli, Paola ^a,b   Solla, Raffaele ^c   Salvatore, Marco ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b INFN SEZIONE DI NAPOLI   (Italy)

^c CNR   (Italy)

Author keywords

Biodosimetry; Breast cancer; Chromosomal aberrations; FISH; Radiotherapy

Indexed keywords

CHEMOTHERAPY; FLUORESCENCE; IRRADIATION; RADIOTHERAPY; SURGERY; TUMORS;

CHROMOSOMAL ABERRATIONS;

ONCOLOGY;

CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE;

ARTICLE; BLOOD SAMPLING; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER SURGERY; CHROMOSOME ABERRATION; CLINICAL ARTICLE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; LYMPHOCYTE; POSTOPERATIVE CARE; PREMATURE CHROMOSOME CONDENSATION; PRIORITY JOURNAL; RADIATION DOSE; SEGMENTAL MASTECTOMY;

EID: 0141615690     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(03)00664-3     Document Type: Article

References (34)

1. Baevens A., Thierens H., Claes K., et al. Chromosomal radiosensitivity in breast cancer patients with a known or putative genetic predisposition. Br J Cancer. 87:2002;1379-1385.
2. Baria K., Warren C., Eden O.B., et al. Chromosomal radiosensitivity in young cancer patients Possible evidence of genetic predisposition . Int J Radiat Biol. 78:2002;341-346.
3. Bondy M.L., Wang L.E., El-Zein R.E., et al. Gamma-radiation sensitivity and risk of glioma. J Natl Cancer Inst. 17:2001;1552-1557.
4. Antoine J.L., Gerber G.B., Leonard A., et al. Chromosome aberrations induced in patients treated with telecobalt therapy for mammary carcinoma. Radiat Res. 86:1981;171-177.
5. Liniecki J., Bajerska A., Wyszynska K. Dose-response relationships for chromosome aberrations in peripheral blood lymphocytes after whole- and partial-body irradiations. Mutat Res. 110:1983;83-101.
6. Martin R.H., Rademaker A., Hildebrand K., et al. A comparison of chromosomal aberrations induced by in vivo radiotherapy in human sperm and lymphocytes. Mutat Res. 226:1989;21-26.
7. Rigaud O., Guedeney G., Duranton I., et al. Genotoxic effects of radiotherapy and chemotherapy on the circulating lymphocytes of breast cancer patients. I. Chromosome aberrations induced in vivo. Mutat Res. 242:1990;17-27.
8. Brandan M.E., Perez-Pastenes M.A., Ostrosky-Wegman P., et al. Mean dose to lymphocytes during radiotherapy treatments. Health Phys. 67:1994;326-329.
9. Kleinerman R.A., Littlefield L.G., Tarone R.E., et al. Chromosome aberrations in lymphocytes from women irradiated for benign and malignant gynecological diseases. Radiat Res. 139:1994;40-46.
10. Fong L., Chen J.-Y., Ting L.-L., et al. Chromosomal aberrations induced in human lymphocytes after partial-body irradiation. Radiat Res. 144:1995;97-101.
11. Gebhart E., Neubauer S., Schmitt G., et al. Use of three-color chromosome in situ suppression technique for the detection of past radiation exposure. Radiat Res. 145:1996;47-52.
12. Matsuoka A., Yamada K., Hayashi M., Sofuni T. Chromosomal aberrations detected by chromosome painting in lymphocytes from cancer patients given high doses of therapeutic X-rays. J Radiat Res. 37:1996;257-265.
13. Huber R., Braselman H., Kulka U., et al. Follow-up analysis of translocations and dicentric frequencies, measured by FISH-chromosome painting in breast cancer patients after partial body radiotherapy with little bone marrow exposure. Mutat Res. 446:1999;103-109.
14. Durante M., Yamada S., Ando K., et al. Measurements of equivalent whole-body dose during radiation therapy by cytogenetic methods. Phys Med Biol. 44:1999;1289-1298.
15. Durante M., Yamada S., Ando K., et al. X-rays vs. carbon-ion tumor therapy Cytogenetic damage in lymphocytes . Int J Radiat Oncol Biol Phys. 47:2000;793-798.
16. Dossou J., Lartigau E., M'Kacher R., et al. Biological dosimetry after total body irradiation (TBI) for hematological malignancy patients. Int J Radiat Oncol Biol Phys. 46:2000;123-129.
17. Schmidberger H., Virsik-Koepp P., Rave-Frank M., et al. Reciprocal translocations in patients with testicular seminoma before and after radiotherapy. Int J Radiat Oncol Biol Phys. 50:2001;857-864.
18. Vorobtsova I., Darroudi F., Semyonov A., et al. Analysis of chromosome aberrations by FISH and Giemsa assays in lymphocytes of cancer patients undergoing whole-body irradiation Comparison of in vivo and in vitro irradiation . Int J Radiat Biol. 77:2001;1123-1131.
19. Cao J., Liu Y., Sun H., et al. Chromosomal aberrations, DNA strand breaks and gene mutations in nasopharyngeal cancer patients undergoing radiation therapy. Mutat Res. 504:2002;85-90.
20. Magnata S.P., Serafim I., Netto J., et al. Unstable chromosome aberrations in peripheral blood lymphocytes from patients with cervical uterine cancer following radiotherapy. Cell Mol Biol. 48:2002;809-811.
21. Gershkevitsh E., Hildebrandt G., Wolf U., et al. Chromosomal aberrations in peripheral lymphocytes and dose to the active bone marrow in radiotherapy of prostate cancer. Strahlenther Onkol. 178:2002;36-42.
22. Légal J.-D., De Crevoisier R., Lartigau E., et al. Chromosomal aberrations induced by chemotherapy and radiotherapy in lymphocytes from patients with breast carcinoma. Int J Radiat Oncol Biol Phys. 52:2002;1186-1195.
23. Durante M., Furusawa Y., Gotoh E. A simple method for simultaneous interphase-metaphase analysis in biological dosimetry. Int J Radiat Biol. 74:1998;457-462.
24. Gaussen A., Légal J.D., Beron-Gaillard N., et al. Radiosensitivity of human normal and tumoral thyroid cells using fluorescence in situ hybridization and clonogenic survival assay. Int J Radiat Oncol Biol Phys. 44:1999;683-691.
25. Coco-Martin J.M., Mooren E., Ottenheim C., et al. Potential of radiation-induced chromosome aberrations to predict radiosensitivity in human tumor cells. Int J Radiat Biol. 75:1999;1161-1168.
26. Bonassi S., Hagmar L., Strömberg U., et al. Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens. Cancer Res. 60:2000;1619-1625.
27. Durante M., Bonassi S., George K., Cucinotta F.A. Risk estimation based on chromosomal aberrations induced by radiation. Radiat Res. 156:2001;662-667.
28. Cox J.D., Stets J., Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 31:1995;1314-1346.
29. Borgmann K., Roper B., El-Awady R., et al. Indicators of late normal tissue response after radiotherapy for head and neck cancer Fibroblasts, lymphocytes, genetics, DNA repair, and chromosome aberrations . Radiother Oncol. 64:2002;141-152.
30. Neubauer S., Gebhart E., Schmitt G., et al. Is chromosome in situ suppression (CISS) hybridization suited as a predictive test for intrinsic radiosensitivity in cancer patients? Int J Oncol. 8:1996;707-712.
31. Neubauer S., Dunst J., Gebhart E. The impact of complex chromosomal rearrangements on the detection of radiosensitivity in cancer patients. Radiother Oncol. 43:1997;189-195.
32. Yamada S., Durante M., Ando K., et al. Complex-type chromosomal exchanges in blood lymphocytes during radiation therapy correlate with acute toxicity. Cancer Lett. 150:2000;215-221.
33. Ekstrand K.E., Dixon R.L., Plunkett S., Raben M. The calculation of the dose to lymphocytes in external beam radiation therapy. Radiat Res. 85:1981;399-407.
34. Ekstrand K.E., Dixon R.L. Lymphocyte chromosome aberrations in partial-body fractionated radiation therapy. Phys Med Biol. 27:1982;407-411.